Literature DB >> 27538639

SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.

Lan Cheng1, Ling Wang1, Nan-Nan Li1, Wen-Juan Yu1, Xiao-Yi Sun1, Jun-Ying Li1, Dong Zhou1, Rong Peng2.   

Abstract

PURPOSE: A genome-wide association study (GWAS) has recently identified a novel single nucleotide polymorphism (SNP) rs356182 at SNCA that can modulate the risk of Parkinson's disease (PD) in Caucasian ancestry. The present study was designed to clarify the strength of the association in ethnic Chinese population.
METHODS: Using a case-control methodology, we genotyped the SNP rs356182 to investigate the association with risk of PD. A total of 2205 ethnic Han Chinese study subjects comprising 1053 sporadic PD patients (581 males, 472 females) and 1152 controls (604 males, 548 females) were recruited from Mainland China. Additionally, the SHEsis software platform was applied for linkage disequilibrium (LD) analysis between rs356182 and another PD-associated synuclein SNP rs356219 we previously reported.
RESULTS: The frequency of SNCA rs356182-G allele was significantly higher in PD group than that in controls (odds ratio (OR)=1.470, 95% confidence interval (CI): 1.284-1.683, P=2.306E-8). Subjects carrying GG/AG genotype had an increased risk compared with the AA carriers (OR=1.162, 95% CI: 1.143-2.274, P=0.006). Among all the genotypes of rs356182, GG genotype showed the strongest association with risk of PD (GG vs. AG/AA, OR=1.620, 95% CI: 1.368-1.919, P=2.001E-8). However, the gender, onset age, disease duration, Hoehn-Yahr stage, UPDRS scores and other clinical features were similar between GG genotype carriers and non-carriers. No LD between rs356182 and rs356219 was found in our population (r(2)=0.016 and D'=0.163).
CONCLUSION: Our study firstly demonstrates that SNCA rs356182 variant has an increased risk of susceptibility to PD in Han Chinese population. Further functional analysis is required to determine the role of this SNP in development of PD.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Parkinson's disease; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27538639     DOI: 10.1016/j.jns.2016.07.032

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.

Authors:  Clarissa Loureiro das Chagas Campêlo; Regina Helena Silva
Journal:  Parkinsons Dis       Date:  2017-07-11

Review 2.  Parkinson's Disease: From Pathogenesis to Pharmacogenomics.

Authors:  Ramón Cacabelos
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

Review 3.  Genetic Elements at the Alpha-Synuclein Locus.

Authors:  Jordan Prahl; Gerhard A Coetzee
Journal:  Front Neurosci       Date:  2022-07-11       Impact factor: 5.152

Review 4.  Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review.

Authors:  Shu-Fen Liu; Lin-Yi Li; Jian-Long Zhuang; Mi-Mi Li; Li-Chao Ye; Xiang-Rong Chen; Shu Lin; Chun-Nuan Chen
Journal:  Front Neurol       Date:  2022-10-03       Impact factor: 4.086

Review 5.  A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease.

Authors:  Camilla Christina Pedersen; Johannes Lange; Marthe Gurine Gunnarsdatter Førland; Angus D Macleod; Guido Alves; Jodi Maple-Grødem
Journal:  NPJ Parkinsons Dis       Date:  2021-07-01

6.  Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.

Authors:  Clarissa L C Campêlo; Fernanda C Cagni; Diego de Siqueira Figueredo; Luiz G Oliveira; Antônio B Silva-Neto; Priscila T Macêdo; José R Santos; Geison S Izídio; Alessandra M Ribeiro; Tiago G de Andrade; Clécio de Oliveira Godeiro; Regina H Silva
Journal:  Front Aging Neurosci       Date:  2017-06-20       Impact factor: 5.750

7.  SNPs in SNCA, MCCC1, DLG2, GBF1 and MBNL2 are associated with Parkinson's disease in southern Chinese population.

Authors:  Aonan Zhao; Yuanyuan Li; Mengyue Niu; Guanglu Li; Ningdi Luo; Liche Zhou; Wenyan Kang; Jun Liu
Journal:  J Cell Mol Med       Date:  2020-07-11       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.